Publications by authors named "Terry Yip"

Claim this Profile
M
Microbiological Profile of Bacterial Infections in Patients With Cirrhosis Over Time: A 20-year Territory-wide Study.
Jie Cai, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Grace Chung-Yan Lui

Clin Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Assessing HCC risk in HBV indeterminate phase.
Vicki Wing-Ki Hui, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip

Hepatology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuation of the second peak of bimodal recurrence of HBV-related HCC after curative treatment in the antiviral era.
Landon L Chan, Anthony W H Chan, Terry C F Yip, Grace L H Wong, Alvin K H Ngai

J Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypothyroidism and liver-related events risk in patients with metabolic dysfunction-associated steatotic liver disease.
Xinrui Jin, Sherlot Juan Song, Jimmy Che-To Lai, Grace Lai-Hung Wong, Alice Pik-Shan Kong, Terry Cheuk-Fung Yip

Clin Mol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Factors Influencing Specialist Referral Among Individuals Tested Positive for HBsAg in Health Check Programs in Hong Kong.
Henry Lik Yuen Chan, Judy Man Lee Lee, Christie Fung Yin Cheng, Aggie Fung Sheung Chan, Dorothy Man Ching Tung, Patrick Chun Yip Tsoi, Terry Cheuk Fung Yip

J Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populations.
Sherlot Juan Song, Eileen Laureal Yoon, Vincent Wai-Sun Wong, Ae Jeong Jo, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip

Clin Mol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide-1 receptor agonist in large vessel occlusion treated by reperfusion therapy-a phase 2 randomized trial.
Hao Wang, Ho Ko, Thomas W Leung, Junzhe Huang, Junjie Sai, Terry Yip

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular-Kidney-Metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD.
Xiao-Dong Zhou, Qin-Fen Chen, Qiong-Yue Fan, Seung Up Kim, Terry Cheuk-Fung Yip

Hepatology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of self-harm in patients with body dysmorphic disorder: a population-based cohort study.
Wai Kwong Tang, Kelvin K F Tsoi, Terry Cheuk Fung Yip, Vivien Wei Jun Liew, Selina Kit Yi Chan

Front Psychiatry· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of self-harm in patients with hypochondriasis: a population-based cohort study.
Wai Kwong Tang, Kelvin K F Tsoi, Terry Cheuk Fung Yip, Vivien Wei Jun Liew, Selina Kit Yi Chan

Front Psychiatry· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.
Jimmy Che-To Lai, Boyu Yang, Hye Won Lee, Huapeng Lin, Emmanuel A Tsochatzis, Terry Cheuk-Fung Yip

Gut· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Polypharmacy in MASLD-An Overlooked Epidemic Disproportionately Affecting Women and Patients With Cirrhosis.
Mary Yue Wang, Terry Cheuk-Fung Yip

Aliment Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: "Challenges in applying MASLD risk algorithms in pregnancy: A call for adaptation and inclusion".
Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong

J Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HES V2.0: Advancing biomarker-based surveillance for HCC - promise and remaining gaps.
Nana Peng, I-Cheng Lee, Terry Cheuk-Fung Yip, Yi-Hsiang Huang

J Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histological severity and hepatic outcomes in patients with MASLD and discrepant FIB-4 and liver stiffness measurement.
Joseph Rabbat, Boyu Yang, Hye Won Lee, Huapeng Lin, Emmanuel Tsochatzis, Terry Cheuk-Fung Yip

Clin Mol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Foundations of Artificial Intelligence in Hepatology: What a Clinician Needs to Know.
Nana Peng, Sherlot J Song, Vicki Wing-Ki Hui, Jimmy Che-To Lai, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip

J Clin Exp Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between longitudinal weight change and clinical outcome in individuals with MASLD.
Yu Shi, Ruoqi Zhou, Seung Up Kim, Terry Cheuk-Fung Yip, Emmanuel Tsochatzis

Hepatology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Immune Checkpoint Inhibitors and HBV Reactivation in Liver Cancer-Reassurance With Vigilance. Authors' Reply.
Terry Cheuk-Fung Yip, Dorothy Cheuk-Yan Yiu, Stephen Lam Chan

Aliment Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: Antiviral Prophylaxis Mitigates HBV Reactivation Risk During Cancer Immunotherapy: Unresolved Challenges and Future Directions-Authors' Reply.
Landon Long Chan, Dorothy Cheuk-Yan Yiu, Terry Cheuk-Fung Yip, Stephen Lam Chan

Aliment Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: "Significant hepatic fat loss after metabolic dysfunction-associated steatotic liver disease: Beware of misclassification as absence of disease" and "Risk stratification beyond fibrosis in SLD: The case for lifestyle-responsive prognostic tools".
Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong

J Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer.
Dorothy Cheuk-Yan Yiu, Jimmy Che-To Lai, Landon Long Chan, Grace Lai-Hung Wong, Mandy Sze-Man Lai, Terry Cheuk-Fung Yip

Aliment Pharmacol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus-Related Cirrhosis.
Vicki Wing-Ki Hui, Zeyuan Yang, Terry Cheuk-Fung Yip, Ramsey Cheung, Jimmy Che-To Lai

J Viral Hepat· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment.
Stephen Lam Chan, Hui-Chuan Sun, Yang Xu, Hongmei Zeng, Hashem B El-Serag, Terry Cheuk-Fung Yip

Lancet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD.
Xiao-Dong Zhou, Yu-Ting Li, Seung Up Kim, Terry Cheuk-Fung Yip, Salvatore Petta

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Antidiabetic Drug Classes on the Risk of Liver-Related Events in Individuals With T2D and MASLD.
Yu Shi, Seung Up Kim, Terry Cheuk-Fung Yip, Emmanuel Tsochatzis, Salvatore Petta

Clin Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis